Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixiana Acute Stroke Evaluation Registry
NCT03494530Phase 4Completed
- Sponsor
- University of Alberta
- Start
- Jun 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in ischemic stroke, Atrial fibrillation (AFib), sponsored by University of Alberta. Started Jun 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
ischemic strokeAtrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03494530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03494530.